Search clinical trials for: Ophiasis

Total 4 results

Pfizer
In Expanded Access, treating physicians are the Sponsors

Available

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Alopecia Areata
Faculty Hospital Kralovske Vinohrady

Completed

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

Infections | Multiple Sclerosis | Autoimmune Diseases | Diabetes Mellitus, Type 1 | Rheumatoid Arthritis | Vaccine Reaction | Inflammatory Bowel Diseases | Psoriasis | Crohn Disease | Ulcerative Colitis | Down Syndrome | Atopic Dermatitis | Vitiligo | Alopecia Areata | COVID-19 Pandemic | Ankylosing Spondylitis | Lupus Erythematosus and other conditions

Czechia
Northwestern University
Genentech, Inc.

Withdrawn

Efalizumab in the Treatment of Alopecia, Phase II

Alopecia Totalis
King Saud University
Saudi Society of Dermatology and Dermatologic surgery

Completed

Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata

Alopecia Totalis | Alopecia Universalis | Ophiasic Alopecia

Saudi Arabia

3

Subscribe